Charles Theuer - 28 Feb 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Feb 2023
Net transactions value
+$7,600
Form type
4
Filing time
02 Mar 2023, 05:24:47 UTC
Previous filing
03 Feb 2023
Next filing
28 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $304 +200 +0.06% $1.52 340,118 28 Feb 2023 Direct
transaction TCON Common Stock Purchase $7,296 +4,800 +1.4% $1.52 344,918 01 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.